BioCardia CEO Executes Strategic Stock Purchases Amid Regulatory Progress and Clinical Developments
BioCardia, Inc. (NASDAQ:BCDA) President and Chief Executive Officer Peter Altman has completed a series of personal share acquisitions. The transactions, totaling $1,230, were documented in a Form 4 filing submitted to the Securities and Exchange Commission on April 22, 2026. These purchases occurred over a two-day period spanning April 20 and Apri…